Qiagen ( ($QGEN) ) has shared an announcement.
Qiagen has reported that the Netherlands Authority for the Financial Markets (AFM) notified the company of a substantial shareholding disclosure related to Bank of America Corporation. According to the AFM register, Bank of America and its affiliates hold a combined capital and voting interest of 2.98% in Qiagen through a mix of real and potential positions, including ordinary shares, swaps, and indirect holdings via entities such as Merrill Lynch and BofA Securities.
The disclosure details multiple indirect stakes and derivatives-based exposures, underscoring the role of major international financial institutions in Qiagen’s shareholder structure. While Qiagen emphasized that it is not responsible for the accuracy of the AFM notification, the filing signals continued interest from global banking groups in the company’s equity and may be closely watched by investors tracking changes in strategic or institutional ownership levels.
The most recent analyst rating on ($QGEN) stock is a Hold with a $36.00 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Qiagen N.V. is a Netherlands-based life sciences and diagnostics company specializing in sample and assay technologies used in molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its shares are listed on multiple European exchanges as well as the NYSE, reflecting a broad international investor base.
Average Trading Volume: 2,036,289
Technical Sentiment Signal: Sell
Current Market Cap: $6.8B
Find detailed analytics on QGEN stock on TipRanks’ Stock Analysis page.
